Expression of inducible factors reprograms CAR-T cells for enhanced function and safety
Anže Smole(Parker Institute for Cancer Immunotherapy), Daniel J. Powell(Democritus University of Thrace)
Cited by 64
Related Papers
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy
|Nature Communications|2021|320
CAR T Cells Targeting MISIIR for the Treatment of Ovarian Cancer and Other Gynecologic Malignancies
|Molecular Therapy|2019|46
CD5 deletion enhances the antitumor activity of adoptive T cell therapies
|Science Immunology|2024|45